Screening studies typically are abbreviated versions of regulatory-compliant assays and require far less test compound. They allow us to predict results in subsequent regulatory standard GLP-compliant assays.
The following studies efficiently screen many compounds affordably, with shorter turn-around times:
Screening Services & Tests |
Hazard Identification (in vitro) |
---|---|
Ames test |
* |
Gene mutation |
* |
Chromosomal aberration | * |
Micronucleus |
** |
Comet |
* |
Non-disjunction testing using FISH or antikinetochore |
* |
Cytotoxicity & phototoxicity |
* |